FRONTIER PHARMA LIMITED

10130529
Active Wokingham

Management consultancy activities other than financial management

0 employees website.com
Management consultancy activities other than financial management
F

FRONTIER PHARMA LIMITED

10130529

Management consultancy activities other than financial management

Founded 18 Apr 2016 Active Wokingham, United Kingdom 0 employees website.com
Management consultancy activities other than financial management
Accounts Submitted 31 Oct 2025 Next due 31 Jan 2027 6 months remaining
Confirmation Submitted 8 Jun 2026 Next due 15 May 2027 10 months remaining
Net assets £773K £3K 2025 year on year
Total assets £1M £171K 2025 year on year
Total Liabilities £265K £174K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

C/O Flb Accountants Llp 1010 Eskdale Road Winnersh Triangle Wokingham RG41 5TS United Kingdom

Telephone

0800 000 0000

Website

www.example.com

Full company profile for FRONTIER PHARMA LIMITED (10130529), an active company based in Wokingham, United Kingdom. Incorporated 18 Apr 2016. Management consultancy activities other than financial management. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 May → 30 Apr 2025
Type micro-entity
Next accounts 30 Apr 2026
Due by 31 Jan 2027 6 months remaining

Net Assets, Total Assets & Total Liabilities (2017–2025)

Cash in Bank

N/A

Net Assets

£772.69k

Decreased by £2.64k (-0%)

Total Liabilities

£264.73k

Increased by £174.09k (+192%)

Turnover

N/A

Employees

N/A

Debt Ratio

26%

Increased by 16 (+160%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
30 Apr Year End
2024
30 Apr Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 865,764 Shares £866k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
18 Mar 2021432,882£433k£1
18 Mar 2021432,882£433k£1

Officers

Officers

1 active 2 resigned
Status
Selamoglu, Mehmet LeventDirectorTurkishTurkey6623 Mar 2023Active

Shareholders

Shareholders (3)

Mehmet Levent Selamoglu
50.0%
432,982
Sanja Spasojevic
25.0%
216,491

Persons with Significant Control

Persons with Significant Control (4)

4 Active 1 Ceased

Mehmet Levent Selamoglu

Turkish

Active
Notified 1 Jul 2018
Residence Turkey
DOB September 1959
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Kiren Lee Naidoo

British

Active
Notified 18 Apr 2016
Residence United Kingdom
DOB June 1985
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Mr Kiren Lee Naidoo

British

Active
Notified 18 Apr 2016
Residence United Kingdom
DOB June 1985
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Mr Mehmet Levent Selamoglu

Turkish

Active
Notified 1 Jul 2018
Residence Turkey
DOB September 1959
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Mr Kiren Lee Naidoo

Ceased 1 May 2026

Ceased

Group Structure

Group Structure

FRONTIER PHARMA LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
8 Jun 2026Confirmation StatementConfirmation statement made on 1 May 2026 with updates
29 May 2026Persons With Significant ControlCessation of Kiren Lee Naidoo as a person with significant control on 1 May 2026
28 Jan 2026OfficersTermination of Esra Selamoglu as director on 26 Jan 2026
31 Oct 2025AccountsAnnual accounts made up to 30 Apr 2025
6 May 2025Confirmation StatementConfirmation statement made on 1 May 2025 with no updates
8 Jun 2026 Confirmation Statement

Confirmation statement made on 1 May 2026 with updates

29 May 2026 Persons With Significant Control

Cessation of Kiren Lee Naidoo as a person with significant control on 1 May 2026

28 Jan 2026 Officers

Termination of Esra Selamoglu as director on 26 Jan 2026

31 Oct 2025 Accounts

Annual accounts made up to 30 Apr 2025

6 May 2025 Confirmation Statement

Confirmation statement made on 1 May 2025 with no updates

Recent Activity

Latest Activity

Confirmation statement made on 1 May 2026 with updates

4 weeks ago on 8 Jun 2026

Cessation of Kiren Lee Naidoo as a person with significant control on 1 May 2026

1 months ago on 29 May 2026

Termination of Esra Selamoglu as director on 26 Jan 2026

5 months ago on 28 Jan 2026

Annual accounts made up to 30 Apr 2025

8 months ago on 31 Oct 2025

Confirmation statement made on 1 May 2025 with no updates

1 years ago on 6 May 2025